Knorr A, Garthoff B
Arch Int Pharmacodyn Ther. 1984 Jun;269(2):316-22.
The relationship between pre-treatment blood pressure and its reduction by the calcium antagonist nitrendipine (NIT) and the vasodilator hydralazine (HYD) was studied in conscious normotensive Wistar Kyoto (WKY) and spontaneously hypertensive rats (SHR). In SHR the correlation was linear and similar after NIT and HYD. In WKY, however, the hypotensive effect of HYD was greater than that of NIT. As revealed by the dose-response curves in SHR both drugs produce similar maximal drops in blood pressure by about 54%. In WKY, HYD also caused a similar relative reduction in blood pressure. In contrast, after NIT initial blood pressure was reduced by only 27% at maximum. The greater hypotensive effect of HYD in WKY is not caused by impaired sympathetic counterregulation since in both substrains tachycardia was more prominent after HYD. Possible mechanisms of the enhanced depressor action of NIT in hypertension are discussed.
在清醒的正常血压Wistar Kyoto(WKY)大鼠和自发性高血压大鼠(SHR)中,研究了治疗前血压及其通过钙拮抗剂尼群地平(NIT)和血管扩张剂肼屈嗪(HYD)降低之间的关系。在SHR中,NIT和HYD后的相关性呈线性且相似。然而,在WKY中,HYD的降压作用大于NIT。正如SHR中的剂量反应曲线所示,两种药物使血压产生的最大降幅相似,约为54%。在WKY中,HYD也导致血压有类似的相对降低。相比之下,NIT后初始血压最大仅降低27%。WKY中HYD更大的降压作用并非由交感神经反调节受损引起,因为在两个亚系中,HYD后心动过速更为明显。文中讨论了高血压中NIT降压作用增强的可能机制。